Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

June H. Myklebust, Joshua Brody, Holbrook E. Kohrt, Arne Kolstad, Debra K. Czerwinski, Sébastien Wälchli, Michael R. Green, Gunhild Trøen, Knut Liestøl, Klaus Beiske, Roch Houot, Jan Delabie, Ash A. Alizadeh, Jonathan M. Irish, Ronald Levy

Blood (2017) 129 (6): 759–770.

https://doi.org/10.1182/blood-2016-05-718494

Published: 2017

Includes: Supplemental data

Journal Articles

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma

Marianne Brodtkorb, Ole Christian Lingjærde, Kanutte Huse, Gunhild Trøen, Marit Hystad, Vera I. Hilden, June H. Myklebust, Ellen Leich, Andreas Rosenwald, Jan Delabie, Harald Holte, Erlend B. Smeland

Blood (2014) 123 (7): 1051–1054.

https://doi.org/10.1182/blood-2013-07-512392

Published: 2014

Includes: Supplemental data

Journal Articles

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

Michael R. Green, Andrew J. Gentles, Ramesh V. Nair, Jonathan M. Irish, Shingo Kihira, Chih Long Liu, Itai Kela, Erik S. Hopmans, June H. Myklebust, Hanlee Ji, Sylvia K. Plevritis, Ronald Levy, Ash A. Alizadeh

Blood (2013) 121 (9): 1604–1611.

https://doi.org/10.1182/blood-2012-09-457283

Published: 2013

Includes: Supplemental data

Journal Articles

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells

June H. Myklebust, Jonathan M. Irish, Joshua Brody, Debra K. Czerwinski, Roch Houot, Holbrook E. Kohrt, John Timmerman, Jonathan Said, Michael R. Green, Jan Delabie, Arne Kolstad, Ash A. Alizadeh, Ronald Levy

Blood (2013) 121 (8): 1367–1376.

https://doi.org/10.1182/blood-2012-04-421826

Published: 2013

Includes: Supplemental data

Journal Articles

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

Ash A. Alizadeh, Andrew J. Gentles, Alvaro J. Alencar, Chih Long Liu, Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Shuchun Zhao, Yasodha Natkunam, Ranjana H. Advani, Randy D. Gascoyne, Javier Briones, Robert J. Tibshirani, June H. Myklebust, Sylvia K. Plevritis, Izidore S. Lossos, Ronald Levy

Blood (2011) 118 (5): 1350–1358.

https://doi.org/10.1182/blood-2011-03-345272

Published: 2011

Includes: Supplemental data

Journal Articles

Bone Morphogenetic Proteins Inhibit CD40L- and IL-21-Induced Ig Production In Human B Cells: Differential Effects of BMP-6 and BMP-7

Kanutte Huse, Maren Bakkeb∅, Lise Forfang, Vera I. Hilden, Erlend B. Smeland, June H. Myklebust

Blood (2010) 116 (21): 1745.

https://doi.org/10.1182/blood.V116.21.1745.1745

Published: 2010

Journal Articles

A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling.

June H Myklebust, PhD, Jonathan M Irish, PhD, Roch Houot, MD, Joshua Brody, MD, Debra K Czerwinski, Ash A Alizadeh, MD, PhD, Arne Kolstad, MD, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 759.

https://doi.org/10.1182/blood.V114.22.759.759

Published: 2009

Journal Articles

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

Roch Houot, MD, Matthew J Goldstein, Holbrook E Kohrt, MD, June H Myklebust, PhD, Ash A Alizadeh, MD, PhD, Jack T Lin, PhD, Jonathan M Irish, PhD, James A Torchia, Arne Kolstad, MD, PhD, Lieping Chen, MD, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 722.

https://doi.org/10.1182/blood.V114.22.722.722

Published: 2009

Journal Articles

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T reg depletion

Roch Houot, Matthew J. Goldstein, Holbrook E. Kohrt, June H. Myklebust, Ash A. Alizadeh, Jack T. Lin, Jonathan M. Irish, James A. Torchia, Arne Kolstad, Lieping Chen, Ronald Levy

Blood (2009) 114 (16): 3431–3438.

https://doi.org/10.1182/blood-2009-05-223958

Published: 2009

Includes: Supplemental data

Journal Articles

A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients

Andrew J. Gentles, Ash A. Alizadeh, Su-In Lee, June H. Myklebust, Catherine M. Shachaf, Babak Shahbaba, Ronald Levy, Daphne Koller, Sylvia K. Plevritis

Blood (2009) 114 (15): 3158–3166.

https://doi.org/10.1182/blood-2009-02-202465

Published: 2009

Includes: Supplemental data

Journal Articles

Signaling Diversity in Human Lymphoma B Cells and in Tumor Infiltrating T Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes

Jonathan M. Irish, PhD, Roch Houot, MD, June H. Myklebust, PhD, Debra K. Czerwinski, Garry P. Nolan, PhD, Ronald Levy, MD

Blood (2008) 112 (11): 377.

https://doi.org/10.1182/blood.V112.11.377.377

Published: 2008

Journal Articles

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Kanutte Huse, M.S, Maren Bakkebo, M.S, Morten Oksvold, PhD, Erlend B. Smeland, MD, PhD, June H. Myklebust, PhD

Blood (2007) 110 (11): 2605.

https://doi.org/10.1182/blood.V110.11.2605.2605

Published: 2007

Journal Articles

Characterization of Early Human B Cell Development by Gene Expression Profiling.

Marit E. Hystad, PhD, Trond H. Bo, PhD, Edith Rian, PhD, June H. Myklebust, PhD, Einar Sivertsen, MD, Lise Forfang, Michael Chiorazzi, Andreas Rosenwald, MD, Inge Jonassen, PhD, Louis M. Staudt, MD,PhD, Erlend B. Smeland, MD,PhD

Blood (2006) 108 (11): 1352.

https://doi.org/10.1182/blood.V108.11.1352.1352

Published: 2006

Journal Articles

B Cell Lymphomas Are Resistant towards Bone Morphogenetic Protein (BMP) Induced Growth Inhibition.

Kanutte Huse, MS, Marianne B. Eide, MD, Christian Kersten, MD, Erlend B. Smeland, MD, PhD, June H. Myklebust, PhD

Blood (2006) 108 (11): 2381.

https://doi.org/10.1182/blood.V108.11.2381.2381

Published: 2006

NARROW

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

Bone Morphogenetic Proteins Inhibit CD40L- and IL-21-Induced Ig Production In Human B Cells: Differential Effects of BMP-6 and BMP-7

A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling.

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T reg depletion

A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients

Signaling Diversity in Human Lymphoma B Cells and in Tumor Infiltrating T Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Characterization of Early Human B Cell Development by Gene Expression Profiling.

B Cell Lymphomas Are Resistant towards Bone Morphogenetic Protein (BMP) Induced Growth Inhibition.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only